<- Back to digest

JOA - 2026-10-01 - Journal Article

Risk of Revision for Periprosthetic Fracture Following Cementless Total Hip Arthroplasty Using a Specific Type 1 Blade Design Stem: A Registry-Based Cohort Study.

Sheth DS, Chang RN, Prentice HA, Fasig BH, Mohan V, Paxton EW

retrospective cohortLOE IIIn = 76,909 (9,425 blade stem; 67,484 other stems)90-day revision endpoint; registry data 2010–2022.

Topics

arthroplasty
PMID: 41577306DOI: 10.1016/j.arth.2026.01.051View on PubMed ->

Key Takeaway

A specific Type 1 blade design cementless femoral stem carries a 2.19-fold higher risk of 90-day periprosthetic fracture revision compared to all other stems (HR=2.19, 95% CI 1.60–3.01).

Summary Depth

Choose how much analysis to show on this article page.

Summary

This registry-based cohort study compared 90-day revision risk for periprosthetic fracture and aseptic failure between a specific Type 1 blade design cementless stem and all other cementless stems in primary THA for osteoarthritis. Multivariable Cox regression demonstrated the blade stem carried HR=2.19 for PPF revision and HR=1.84 for aseptic revision versus all comparators. The elevated PPF risk persisted when the blade stem was isolated against Type 1 (HR=2.19), Type 2 (HR=2.12), and Type 5 stems (aseptic HR=4.71), indicating a design-specific rather than class-specific effect.

Key Limitation

The specific implant is not identified by name, limiting direct translation to implant selection decisions at the point of care.

Original Abstract

BACKGROUND

Implant survival following total hip arthroplasty (THA) may differ by femoral stem design. In a series of patients, a consistent pattern of low-energy periprosthetic fracture (PPF) with a specific blade design stem was observed. Therefore, we conducted a cohort study comparing revision risk with a specific stem to other stems.

METHODS

Adult patients who underwent primary cementless THA for osteoarthritis with a highly crosslinked polyethylene liner and large femoral head (≥ 28 mm) were identified using data from a United states-based health care system's registry (2010 to 2022). There were 9,425 THAs using the specific blade stem compared to 67,484 THAs using other stems. Multivariable Cox regressions were used to evaluate the 90-day revision due to PPF and aseptic revision.

RESULTS

The crude PPF revision incidence was 0.8 and 0.4% for the specific blade stem and other stems, respectively. In adjusted analyses, a higher risk of PPF revision (hazard ratio [HR] = 2.19, 95% confidence interval [CI] = 1.60 to 3.01) and aseptic revision (HR = 1.84, 95% CI = 1.40 to 2.42) with the specific blade stem was observed. This higher risk was observed when comparing the specific blade stem to other type 1 stems (PPF: HR = 2.19, 95% CI = 1.54 to 3.11; aseptic: HR = 1.56, 95% CI = 1.14 to 2.12) as well as to type 2 stems (PPF: HR = 2.12, 95% CI = 1.48 to 3.05; aseptic: HR = 1.90, 95% CI = 1.41 to 2.56), and to type 5 stems (aseptic: HR = 4.71, 95% CI = 2.03 to 10.92).

CONCLUSIONS

While revision incidence was low, the specific blade stem was associated with a two-time higher risk of 90-day PPF revision when compared to other stems. These findings may guide surgeons in stem selection where PPF is a concern.

LEVEL OF EVIDENCE

Level III.